By Adam Bonislawski

Researchers at Arizona State University's Biodesign Institute have received a three-year, $4 million grant from the National Institutes of Health to develop a high-throughput pipeline for generating synthetic affinity reagents called DNA synbodies.

Consisting of pairs of peptides linked by a DNA backbone, these reagents are significantly easier and cheaper to produce than conventional affinity reagents like antibodies and, in early studies, have shown equivalent or better sensitivity and specificity.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

As the UN ponders a ban on gene drives, one malaria researchers says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.